농업용 생물제제 시험 시장 - 예측(2026-2031년)

Agriculture Biologicals Testing Market is forecasted to rise at a 7.52% CAGR, reaching USD 3.221 billion in 2031 from USD 2.085 billion in 2025.

Agriculture biologicals encompass a diverse portfolio of non-synthetic inputs-microbial inoculants (rhizobia, mycorrhizae, Trichoderma, Bacillus spp., PGPR), biostimulants (seaweed extracts, humic/fulvic acids, protein hydrolysates, phosphites), biofertilizers, and bioactive soil amendments (biochar, compost extracts)-designed to enhance nutrient uptake, stress resilience, and yield potential while reducing reliance on conventional agrochemicals. The associated testing market provides essential third-party analytical services for product registration, label claims verification, quality control, and efficacy demonstration under schemes such as EU Fertilising Products Regulation (FPR 2019/1009), USDA NOP, Canada CFIA, and various national organic standards.

Demand is structurally propelled by three interlocking forces. First, tightening regulatory restrictions on synthetic pesticides and mineral fertilizers-exemplified by the EU Farm-to-Fork 25 % organic land target by 2031 and national bans on glyphosate and neonicotinoids-are creating an irreversible push toward biologically based crop management systems. Second, retailer and food-processor sustainability mandates (e.g., Regenerative Organic Certified, Scope 3 decarbonization commitments) increasingly require verifiable use of biological inputs, driving manufacturers to invest in rigorous, accredited testing to differentiate genuine efficacy from commodity offerings. Third, the rapid expansion of the biostimulant category-now the fastest-growing segment within biologicals-necessitates sophisticated analytical protocols for quantifying active compounds, microbial viability (CFU/g), and plant-response biomarkers under field conditions.

Europe continues to dominate global agriculture biologicals testing volume and value, benefiting from the continent's position as both the largest organic market and the most stringent regulatory environment for novel fertilizing products. The implementation of FPR 2019/1009 has dramatically raised the bar for safety, stability, and efficacy data requirements, effectively mandating third-party GLP/OECD-compliant testing for microbial consortia, contaminant screening (heavy metals, pathogens), and multi-season agronomic performance trials. National organic certification bodies (ECOCERT, Bioland, Soil Association) and private standards (Demeter, BioSuisse) impose additional residue and microbiome-impact assessments that further deepen testing intensity.

The microbial inoculant and biostimulant segments are experiencing the strongest testing demand growth. Manufacturers pursuing EU CMC-7 (microbial plant biostimulant) or CMC-1 (micro-organism) claims must now provide whole-genome sequencing, taxonomic identification via 16S/ITS, plant-growth promotion assays under controlled conditions, and persistence studies in soil/rhizosphere. Similarly, seaweed-extract and protein-hydrolysate biostimulants require precise quantification of signaling molecules (betaines, polyamines, brassinosteroids) and amino-acid profiling to support label claims on drought tolerance, root development, or nutrient-use efficiency.

North America is emerging as the second major testing hub, driven by accelerating USDA NOP accreditation needs, state-level carbon farming incentives (California Healthy Soils Program), and the rapid scale-up of biologicals by major crop-protection players pivoting toward integrated biological platforms. The convergence of regenerative agriculture initiatives from food companies and the need for verifiable carbon-sequestration credits are creating new demand for soil health testing panels that include biological activity metrics (enzyme assays, PLFA, qPCR microbial abundance).

Competitive differentiation among testing laboratories increasingly hinges on accreditation scope (ISO 17025, GLP, ISTA), speed-to-result for time-sensitive microbial viability testing, and ability to offer multi-omic characterization (metagenomics, metabolomics) that supports premium product positioning. Laboratories capable of delivering fully compliant EU FPR dossiers or USDA biopesticide/biofertilizer registration packages under one roof command significant pricing power.

In conclusion, the agriculture biologicals testing market has evolved from a niche compliance function into a critical enabling infrastructure for the global transition to sustainable intensification. With Europe's regulatory framework setting the global gold standard and an accelerating corporate shift toward biological portfolios, demand for sophisticated, accredited testing services is locked into a multi-year structural uptrend that shows no sign of saturation.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Agriculture Biologicals Testing Market Segmentation:

BY PRODUCT

• Biopesticides
• Biofertilizers
• Biostimulants
• Others

BY APPLICATION

• Field Support
• Regulatory
• Analytical
• Others

BY GEOGRAPHY

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AGRICULTURE BIOLOGICALS TESTING MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Biopesticides
• 5.3. Biofertilizers
• 5.4. Biostimulants
• 5.5. Others

6. AGRICULTURE BIOLOGICALS TESTING MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Field Support
• 6.3. Regulatory
• 6.4. Analytical
• 6.5. Others

7. AGRICULTURE BIOLOGICALS TESTING MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Anadiag Group
• 9.2. Apal Agricultural Laboratory
• 9.3. Bionema Limited
• 9.4. Biotecnologie B.T. Srl
• 9.5. Eurofins Scientific SE
• 9.6. i2LResearch
• 9.7. Laus GmbH
• 9.8. RJ Hill Laboratories Ltd
• 9.9. SGS SA
• 9.10. Staphyt S.A.

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key Benefits for the Stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations